News

Capricor Therapeutics said on Monday the U.S. Food and Drug Administration (FDA) plans to convene a panel of outside experts ...
From STAT’s Adam Feuerstein: The FDA informed Capricor Therapeutics that a meeting of outside experts will be convened to ...
The FDA’s user free programs account for just under half of the agency’s budget—money that could be imperiled by the recent ...
Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...
The FDA has approved a dihydroergotamine-based nasal powder for the acute treatment of migraine with or without aura in ...
The FDA has rehired at least some workers tasked with releasing public records generated by the agency's regulatory ...
Fresh produce industry frontlines its own rigorous, science-driven standards – epitomized by a self-funded enforcement model ...
Liquidia's legal win clears the path for Yutrepia's FDA approval by May 2025. Learn how its advantages position it to compete ...